Fingerprint Cards AB (publ) will present at Aktiedagarna in Stockholm on June 12, 2024
Fingerprints’ President & CEO, Adam Philpott, will present the company at Aktiedagarna in Stockholm, an investor event organized by Aktiespararna.…
Brand Post
Noble Corporation plc announces agreement to acquire Diamond Offshore Drilling, Inc.
SUGAR LAND, Texas, June 10, 2024 /PRNewswire/ — Noble Corporation plc (“Noble”) (CSE: NOBLE) (NYSE: NE) and Diamond Offshore Drilling,…
J INTS BIO, ASCO 2024 – JIN-A02 showed tumor reductions including brain metastasis in the ongoing first-in-human, dose-finding Phase 1 clinical study
SEOUL, South Korea, June 10, 2024 /PRNewswire/ — J INTS BIO provided an update of its ongoing Phase 1 clinical…
DeepQure receives IDE Approval from FDA for its EFS study to treat Resistant Hypertension with its Extravascular Renal Denervation Technology (HyperQure™)
SEOUL, South Korea, June 10, 2024 /PRNewswire/ — DeepQure, a Seoul based medical device company with a novel, extravascular (laparoscopic…
Roche four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and RSV receives U.S. FDA Emergency Use Authorization
The test uses highly sensitive PCR technology, requiring only a single nasal-swab sample to provide rapid, accurate qualitative detection and…
Build-A-Bear Celebrates International Day of Play with ‘The Stuff You Love’: Free Lil Cub Bears, Heartwarming Donations and Fun for Kids
Experience the Magic of Play with Build-A-Bear’s Heartfelt Initiatives ST. LOUIS, June 10, 2024 /PRNewswire/ — Build-A-Bear Workshop, Inc. (NYSE:…
European Commission approves Roche’s Alecensa as the first and only targeted adjuvant treatment for people with ALK-positive early-stage lung cancer
European Commission approves Roche’s Alecensa as the first and only targeted adjuvant treatment for people with ALK-positive early-stage lung cancer…
Press release Biocartis NV: Biocartis Welcomes Gina Wallar, PhD as Chief Business Officer and Judith Vacchino, PhD as VP Global Marketing
PRESS RELEASE – 10/06/2024, 07:00 CEST Biocartis Welcomes Gina Wallar, PhD as Chief Business Officer and Judith Vacchino, PhD as VP…
IMCD Italy expands its Pharmaceuticals presence with the acquisition of Selechimica
IMCD_logo Logo IMCD ROTTERDAM, The Netherlands (10 June 2024) – IMCD N.V. (“IMCD” or “Company”), a leading distributor of speciality…
Santhera Announces Launch of Early Access Program in China for AGAMREE® by its Partner Sperogenix
Pratteln, Switzerland, June 10, 2024 – Santhera Pharmaceuticals (SIX: SANN) announces that its partner Sperogenix Therapeutics has launched a paid-for Early…
Pressidium® Introduces New Hosting Plans and Global Data Centers
Elevating Performance and Reach for WordPress Users Worldwide LONDON, June 10, 2024 /PRNewswire/ — Pressidium® is transforming Managed WordPress Hosting…
PROOF Hard Ice Cream Plays to Crowds at Summerfest 2024
First-ever Regulated Alcohol Level (5% ABV) Ice Cream Available at Wisconsin’s Summerfest COLUMBIA, S.C., June 10, 2024 /PRNewswire/ — PROOF Hard…
Hepsor’s Canadian subsidiary made its third investment in the Canadian real estate market
Hepsor SPV I Ltd, a Ontario-based subsidiary of Hepsor AS, made its third investment in the Canadian real estate market.…
New Book Shares the Keys Unlocking the Life-Transforming Power of Mindset
Speaker, Author and Hypnotic Coach reveals the secrets to letting go of the past to create a better future LONGMONT,…
FDA accepts filing of Leqembi® (lecanemab-irmb) sBLA for IV maintenance dosing for the treatment of early Alzheimer’s Disease
STOCKHOLM, June 10, 2024 /PRNewswire/ — BioArctic AB’s (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that that the…
↑